Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors using a platform of primary human cell based disease models, BioMAP® systems
Primary Human Cell Systems Analysis of Drug Mechanisms
BioMAP® Primary Human Cell-Based Systems for Drug Discovery
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human Cell Systems
A BioMAP® System in Detail
Introduction to BioMAP® Systems
Methods and Approaches for Defining Mechanism Signatures from Human Primary Cell-Based Disease Models
BioMAP® Database Overview
BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek EPA ToxCast Program
